eHealth (EHTH)
(Delayed Data from NSDQ)
$4.86 USD
-0.17 (-3.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.86 USD
-0.17 (-3.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Zacks News
Willis Towers Watson (WTW) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 9.33% and 0.41%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Q3 Earnings Meet Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 0% and 0.01%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Arthur J. Gallagher (AJG) Matches Q3 Earnings Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 0% and 0.15%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Incurs Q2 Loss on Weak Employer and Individual Unit
by Zacks Equity Research
eHealth's (EHTH) second-quarter results reflect higher marketing costs. The Medicare segment performed well while the Employer and Individual segment suffered a setback.
EHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -53.52% and 18.04%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Beats Q2 Earnings Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 1.75% and 1.50%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Q2 Earnings Miss Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of -5.18% and 1.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 11.84% and 0.03%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Brown & Brown (BRO) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 6.90% and 3.36%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
EHealth (EHTH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -102.56% and 19.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Meets Q1 Earnings Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 0% and 0.24%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of -3.41% and 1.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Q4 Earnings Miss on Higher Operating Costs
by Zacks Equity Research
eHealth (EHTH) expects revenues to be in the range of $450-$475 million in 2024.
EHealth (EHTH) Misses Q4 Earnings Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -17.01% and 1.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Exploring the Driving Forces Behind eHealth's (EHTH) Q4 Earnings
by Zacks Equity Research
eHealth's (EHTH) fourth-quarter 2023 results are likely to reflect higher expenses and Individual, Family and Small Business segment revenues.
eHealth (EHTH) Surges 20.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
eHealth (EHTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Aon (AON) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of 4.04% and 2.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 8.21% and 4.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Hold Strategy is Apt for eHealth (EHTH) Stock Now
by Zacks Equity Research
eHealth's (EHTH) transformation initiatives are lowering its costs and expanding margins.
eHealth (EHTH) Soars 13.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
eHealth (EHTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
eHealth (EHTH) Revises 2023 Guidance: Here's What We Think
by Zacks Equity Research
eHealth (EHTH) anticipates its adjusted EBITDA for 2023 to be within a loss of $3 million and a profit of $17 million, which shows significant improvement from the previous guidance.
EHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -10.53% and 33.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 7.14% and 2.17%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Q2 Earnings Lag Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of -13.87% and 1.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Why You Should Consider Buying Brown & Brown (BRO) Stock
by Zacks Equity Research
New businesses, better customer retention, premium-rate increases across the majority of business lines, strategic acquisitions and a strong financial position poise Brown & Brown (BRO) for growth.